急性胰腺炎的诊断:血清脂肪酶未升高三倍患者的临床与影像学特征分析
该回顾性研究纳入234例急性胰腺炎患者,其中64例(27%)血清脂肪酶未升高三倍(Lip-组),170例为Lip+组。Lip-组男性及复发性急性胰腺炎比例显著更高,EPIC评分显著更低,两组胰腺及非胰腺原因死亡率无显著差异。结论认为Lip-患者若无增强CT确诊可能被漏诊,男性复发性急性胰腺炎患者最可能从增强CT中获益。
要点
- 27%的急性胰腺炎患者血清脂肪酶未升高三倍,仅凭实验室指标可能漏诊。
- Lip-组男性占78%、复发性急性胰腺炎占63%,均显著高于Lip+组。
- Lip-组EPIC评分显著低于Lip+组,提示该评分可能低估Lip-患者病情。
核心结论
- 27%的急性胰腺炎患者血清脂肪酶未升高三倍,若无增强CT确诊可能被漏诊;男性复发性急性胰腺炎患者最可能从增强CT中获益。
研究设计与样本
- 回顾性、经IRB批准的研究,纳入234例连续急性胰腺炎患者,包括单次发作和复发性发作,均于症状出现后≥72小时行增强CT;由2名观察者评估3种基于CT的评分(CTSI、mCTSI、EPIC),并以入院后48小时C反应蛋白评估严重程度。
关键影像表现/征象
- 增强CT显示Lip-组胸腔积液和腹腔积液计数显著低于Lip+组。
诊断标准与关键数值
- 以血清脂肪酶升高三倍为界将患者分为Lip-组(64/234,27%)和Lip+组(170/234,73%);EPIC评分Lip-组为3(IQR 2-5),Lip+组为2(IQR 1-3),p<0.001。
临床应用与阅片要点
- 对急性腹痛但血清脂肪酶未升高三倍的患者,尤其男性复发性急性胰腺炎患者,应结合增强CT以明确诊断,避免漏诊。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Diagnosing acute pancreatitis (AP) may be challenging in patients with acute abdominal pain but missing threefold increased serum lipase levels (Lip-). This studyaims both to characterize these patients using clinical, radiological and mortality data, and to assess the group of patients who need contrast-enhanced computed tomography (CECT).
METHODS: In this retrospective, IRB approved study 234 consecutive patients with AP were investigated. Inclusion criteria were single (SAP) and recurrent attacks (RAP) of AP and CECT ≥72h after onset of symptoms. Severity of AP was assessed by C-reactive protein at 48h after hospital admission and using 3 CT-based scores (CTSI, mCTSI, EPIC) by 2 observers. Mortality rates from pancreatic and non-pancreatic causes were noted with regard to lipase increase. Results were compared with paired t-test and Wilcoxon signed-rank test.
RESULTS: 64/234 (27%) patients belonged to Lip- group and 170/234 (73%) patients were allocated to Lip+ group. Significantly more male patients (78% in Lip- vs. 63% in Lip+, p<0.05) with RAP (63% in Lip- vs. 21% in Lip+, p<0.001) were observed in the Lip- group. EPIC was significantly lower in Lip- group compared to Lip+ group (3(IQR 2-5) vs. 2(IQR 1-3), p<0.001). Mortality from pancreatic and non-pancreatic causes was comparable in Lip- and Lip+ group (pancreatic causes: 9% vs. 6%, p=0.60; nonpancreatic causes: 8% vs. 5%, p=0.58).
CONCLUSIONS: 27% of all patients with AP presented without threefold increase of lipase levels. Thus, they would be underdiagnosed without confirming CECT, which revealed significantly lower counts of pleural effusions and ascites. Male patients with RAP were found significantly more often among the Lip- group. Hence, they would benefit the most from CECT for diagnosing AP.
引用
- Avanesov M, Löser A, Keller S, et al. Diagnosing acute pancreatitis-Clinical and radiological characterisation of patients without threefold increase of serum lipase. Eur J Radiol. 2017. PMID: 28987680. doi:10.1016/j.ejrad.2017.08.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。